Wall Street analysts expect Docusign Inc (NASDAQ:DOCU) to report $208.49 million in sales for the current quarter, according to Zacks Investment Research. Six analysts have made estimates for Docusign’s earnings. The highest sales estimate is $213.09 million and the lowest is $206.40 million. Docusign reported sales of $155.81 million in the same quarter last year, which suggests a positive year over year growth rate of 33.8%. The firm is scheduled to report its next earnings report on Thursday, June 6th.
According to Zacks, analysts expect that Docusign will report full-year sales of $913.96 million for the current fiscal year, with estimates ranging from $912.20 million to $920.16 million. For the next financial year, analysts anticipate that the business will report sales of $1.13 billion, with estimates ranging from $1.10 billion to $1.14 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Docusign.
Docusign (NASDAQ:DOCU) last released its quarterly earnings results on Thursday, March 14th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.23) by ($0.01). Docusign had a negative net margin of 60.84% and a negative return on equity of 86.06%. The business had revenue of $199.73 million during the quarter, compared to the consensus estimate of $193.63 million. The firm’s revenue for the quarter was up 34.2% compared to the same quarter last year.
In related news, CRO Loren Alhadeff sold 8,717 shares of Docusign stock in a transaction dated Tuesday, March 19th. The stock was sold at an average price of $56.04, for a total value of $488,500.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kirsten O. Wolberg sold 10,166 shares of the business’s stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $52.95, for a total value of $538,289.70. The disclosure for this sale can be found here. Over the last quarter, insiders sold 709,378 shares of company stock valued at $34,993,383.
Several institutional investors have recently bought and sold shares of the company. Edge Wealth Management LLC grew its position in shares of Docusign by 34.4% during the 1st quarter. Edge Wealth Management LLC now owns 56,622 shares of the company’s stock worth $2,942,000 after buying an additional 14,484 shares during the period. Sonora Investment Management LLC acquired a new position in shares of Docusign during the 1st quarter worth about $31,000. Legacy Advisors LLC acquired a new position in shares of Docusign during the 1st quarter worth about $38,000. Underhill Investment Management LLC grew its position in shares of Docusign by 31.6% during the 1st quarter. Underhill Investment Management LLC now owns 166,390 shares of the company’s stock worth $8,626,000 after buying an additional 39,950 shares during the period. Finally, Selective Wealth Management Inc. acquired a new position in shares of Docusign in the 1st quarter valued at approximately $8,871,000. Institutional investors own 53.14% of the company’s stock.
Docusign stock opened at $55.35 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. Docusign has a 12-month low of $35.06 and a 12-month high of $68.35. The stock has a market capitalization of $9.46 billion and a P/E ratio of -19.09.
DocuSign, Inc provides cloud based transaction products and services in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. It serves large enterprises, sole proprietorships, small- to medium-sized businesses, professionals, and individuals.
Further Reading: Quiet Period
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.